Mark D. Ware

732 total citations
15 papers, 583 citations indexed

About

Mark D. Ware is a scholar working on Molecular Biology, Immunology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mark D. Ware has authored 15 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mark D. Ware's work include Protein Kinase Regulation and GTPase Signaling (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Mast cells and histamine (3 papers). Mark D. Ware is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Mast cells and histamine (3 papers). Mark D. Ware collaborates with scholars based in Canada, United Kingdom and France. Mark D. Ware's co-authors include Gerald Krystal, Jacqueline E. Damen, Sylvie Mazoyer, Michael R. Hughes, Gareth Williams, Olga Anczuków, Usman H. Malabu, Ling Liu, Monique Buisson and Dominique Stoppa‐Lyonnet and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Oncogene.

In The Last Decade

Mark D. Ware

14 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark D. Ware Canada 11 385 138 77 74 74 15 583
Venita DeAlmeida United States 10 390 1.0× 35 0.3× 59 0.8× 116 1.6× 171 2.3× 19 691
Robert G. Collum United States 8 585 1.5× 115 0.8× 94 1.2× 207 2.8× 160 2.2× 11 888
C Bützler Germany 8 511 1.3× 42 0.3× 41 0.5× 30 0.4× 88 1.2× 10 646
William M. Schopperle United States 9 359 0.9× 55 0.4× 25 0.3× 70 0.9× 32 0.4× 15 488
Kazuhiko Haruta Japan 9 129 0.3× 75 0.5× 60 0.8× 57 0.8× 18 0.2× 15 359
Ute C. Rogner France 17 458 1.2× 209 1.5× 80 1.0× 65 0.9× 294 4.0× 32 794
Jo-Anne Herbrick Canada 13 397 1.0× 174 1.3× 31 0.4× 65 0.9× 197 2.7× 17 855
Cyril Esnault France 11 658 1.7× 54 0.4× 113 1.5× 90 1.2× 44 0.6× 16 910
Ulrich Rümenapp Germany 16 671 1.7× 74 0.5× 13 0.2× 48 0.6× 31 0.4× 17 807
Chloë Marden United Kingdom 10 123 0.3× 228 1.7× 13 0.2× 144 1.9× 26 0.4× 13 444

Countries citing papers authored by Mark D. Ware

Since Specialization
Citations

This map shows the geographic impact of Mark D. Ware's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Ware with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Ware more than expected).

Fields of papers citing papers by Mark D. Ware

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Ware. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Ware. The network helps show where Mark D. Ware may publish in the future.

Co-authorship network of co-authors of Mark D. Ware

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Ware. A scholar is included among the top collaborators of Mark D. Ware based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Ware. Mark D. Ware is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Anczuków, Olga, Mark D. Ware, Monique Buisson, et al.. (2007). Does the nonsense-mediated mRNA decay mechanism prevent the synthesis of truncated BRCA1, CHK2, and p53 proteins?. Human Mutation. 29(1). 65–73. 77 indexed citations
2.
Buisson, Monique, et al.. (2006). The 185delAG mutation (c.68_69delAG) in theBRCA1 gene triggers translation reinitiation at a downstream AUG codon. Human Mutation. 27(10). 1024–1029. 41 indexed citations
3.
Ware, Mark D., et al.. (2005). Does nonsense-mediated mRNA decay explain the ovarian cancer cluster region of the BRCA2 gene?. Oncogene. 25(2). 323–328. 42 indexed citations
4.
Damen, Jacqueline E., Mark D. Ware, Janet Kalesnikoff, Michael R. Hughes, & Gerald Krystal. (2001). SHIP's C-terminus is essential for its hydrolysis of PIP3 and inhibition of mast cell degranulation. Blood. 97(5). 1343–1351. 57 indexed citations
5.
Damen, Jacqueline E., Mark D. Ware, Janet Kalesnikoff, & Gerald Krystal. (2000). The proline-rich c-terminus of ship is required for its inhibition of mast cell degranulation. Experimental Hematology. 28(7). 84–85.
6.
Krystal, Gerald, Jacqueline E. Damen, Cheryl D. Helgason, et al.. (1999). Ships ahoy. The International Journal of Biochemistry & Cell Biology. 31(10). 1007–1010. 35 indexed citations
7.
Huber, Michael, Cheryl D. Helgason, Jacqueline E. Damen, et al.. (1999). The role of SHIP in growth factor induced signalling. Progress in Biophysics and Molecular Biology. 71(3-4). 423–434. 49 indexed citations
8.
Sampson, Mike, et al.. (1998). Lack of Relationship Between Sympathetic Nervous System Activity, Measured by Two Circulating Markers, and Blood Pressure in Diabetic and Nondiabetic Subjects. Journal of Diabetes and its Complications. 12(3). 140–146. 5 indexed citations
9.
Damen, Jacqueline E., Ling Liu, Mark D. Ware, et al.. (1998). Multiple Forms of the SH2-Containing Inositol Phosphatase, SHIP, Are Generated by C-Terminal Truncation. Blood. 92(4). 1199–1205. 53 indexed citations
10.
Damen, Jacqueline E., Ling Liu, Mark D. Ware, et al.. (1998). Multiple Forms of the SH2-Containing Inositol Phosphatase, SHIP, Are Generated by C-Terminal Truncation. Blood. 92(4). 1199–1205. 6 indexed citations
11.
Liu, Ling, Jacqueline E. Damen, Mark D. Ware, & Gerald Krystal. (1997). Interleukin-3 Induces the Association of the Inositol 5-Phosphatase SHIP with SHP2. Journal of Biological Chemistry. 272(17). 10998–11001. 71 indexed citations
12.
Liu, Lin, JE Damen, Mark D. Ware, Michael R. Hughes, & Gerald Krystal. (1997). SHIP, a new player in cytokine-induced signalling. Leukemia. 11(2). 181–184. 48 indexed citations
13.
14.
Ware, Mark D., et al.. (1993). Neuropeptide Y Concentrations in Cerebrospinal Fluid are Unchanged in Obesity. Clinical Science. 84(s28). 44P–44P. 3 indexed citations
15.
Dryden, Simon, H. D. McCarthy, Usman H. Malabu, Mark D. Ware, & Gareth Williams. (1993). Increased neuropeptide Y concentrations in specific hypothalamic nuclei of the rat following treatment with methysergide: Evidence that NPY may mediate serotonin's effects on food intake. Peptides. 14(4). 791–796. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Venita DeAlmeida Breakdown of academic impact, for papers by Robert G. Collum Breakdown of academic impact, for papers by C Bützler Breakdown of academic impact, for papers by William M. Schopperle Breakdown of academic impact, for papers by Kazuhiko Haruta Breakdown of academic impact, for papers by Ute C. Rogner Breakdown of academic impact, for papers by Jo-Anne Herbrick Breakdown of academic impact, for papers by Cyril Esnault Breakdown of academic impact, for papers by Ulrich Rümenapp Breakdown of academic impact, for papers by Chloë Marden
Rankless by CCL
2026